Crescent Biopharma announced the pricing of its public offering of 8.09 million ordinary shares and pre-funded warrants for 525,897 shares at about $14.50 each, aiming to raise approximately $125 million before expenses. The offering includes a 30-day option for underwriters to buy an additional 1.29 million shares. Proceeds will support Crescent's clinical-stage oncology programs, including its PD-1 x VEGF bispecific antibody and antibody-drug conjugates. The offering is expected to close on July 16, 2026, pending customary conditions.
SEO Contractor, a digital marketing agency for contractors, earned two new Semrush certifications in AI Search Operating System and SEO Crash Course with Brian Dean, valid through 2027. The agency also holds HubSpot's AEO Fundamentals and UC Davis SE...
Halper Sadeh LLC is investigating whether shareholders of NextEra Energy (NEE), Corebridge Financial (CRBG), RE/MAX Holdings (RMAX), and Apogee Therapeutics (APGE) are receiving fair deals in their companies' proposed mergers or sales. The firm highl...
HUYA has introduced VAM 1.0, an AI-driven digital human model that creates interactive live avatars from a single photo, marking a strategic move into China's expanding virtual persona market. This technology enables scalable, high-margin content pro...
Iran's Islamic Revolutionary Guard Corps launched about ten ballistic missiles at the US Al-Azraq Air Base in Jordan, targeting command centers and drone hangars. Jordan intercepted most missiles, preventing casualties, but some damage occurred. This...
Veea Inc.'s subsidiary in Mexico has begun generating revenue as Telcel starts billing customers for Internet Gestionado, a 5G fixed wireless broadband service integrated with AI-driven cybersecurity. Launched commercially in March 2026, the service ...
